CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 43:48 MissionDMD: FibroGen’s Anti-Fibrosis Program (May 2016) 9 years ago Research & Clinical Trial Webinars,Webinars 53:38 BMS Anti-Myostatin Adnectin Program (March 2016) 9 years ago Research & Clinical Trial Webinars,Webinars 1:13:48 HOPE-Duchenne Trial – Capricor Therapeutics (January 2016) 9 years ago Research & Clinical Trial Webinars,Webinars 1:00:42 Understanding the Potential of Epicatechin (December 2015) 9 years ago Research & Clinical Trial Webinars,Webinars 59:43 Understanding Myostatin Inhibition (November 2015) 9 years ago Research & Clinical Trial Webinars,Webinars 1:02:05 Decode Duchenne Genetic Testing Program (November 2015) 9 years ago Care Webinars,Webinars 1:01:24 PF-06252616 (Anti-Myostatin) Webinar (June 2015) 10 years ago Research & Clinical Trial Webinars,Webinars 41:42 Caregiver Webinar (June 2015) 10 years ago Care Webinars,Webinars «1…1920212223…25»Page 21 of 25
by: Parent Project Muscular Dystrophy
